%0 Journal Article
%T Analysis of serious adverse event: Writing a narrative
%A Indu Nambiar
%J Archive of "Perspectives in Clinical Research".
%D 2018
%R 10.4103/picr.PICR_52_18
%X One of the reasons that a research molecule undergoes through different phases of clinical trials is to establish the safety and efficacy of the drug. To establish the safety profile of any drug, the most important aspect is to evaluate every adverse event (AE) that a clinical trial individual experiences. This detail is provided by any investigator or sponsor through the narratives that is prepared post the analysis of a serious AE. The purpose of this article is to emphasize the importance of these narratives
%K Communications
%K Food and Drug Administration
%K International Council for Harmonisation
%K narratives
%K serious adverse event
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950607/